MMP13 as a stromal mediator in controlling persistent angiogenesis in skin carcinoma

Carcinogenesis

Volumn 31, Issue 7, 2009, Pages 1175-1184

  Lederle, Wiltrud ^a,b   Hartenstein, Bettina ^a   Meides, Alice ^a   Kunzelmann, Heike ^a   Werb, Zena ^c   Angel, Peter ^a   Mueller, Margareta M ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE 3; MESSENGER RNA; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CANCER CELL; CANCER GRAFT; CANCER INVASION; DOWN REGULATION; ENDOTHELIUM CELL; FIBROBLAST; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN CARCINOMA; TUMOR GROWTH; TUMOR VASCULARIZATION; WILD TYPE;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL LINE; MATRIX METALLOPROTEINASE 13; MICE; MICE, INBRED C57BL; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; RNA, MESSENGER; SKIN NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77954379653     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgp248     Document Type: Article

References (54)

1. Egeblad,M. et al. (2002) New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer, 2, 161-174.
2. Lynch,C.C. et al. (2002) Matrix metalloproteinases in tumor-host cell communication. Differentiation, 70, 561-573.
3. Martin,M.D. et al. (2007) The other side of MMPs: protective roles in tumor progression. Cancer Metastasis Rev., 26, 717-724.
4. Ala-aho,R. et al. (2005) Collagenases in cancer. Biochimie, 87, 273-286.
5. Balbin,M. et al. (2001) Identification and enzymatic characterization of two diverging murine counterparts of human interstitial collagenase (MMP-1) expressed at sites of embryo implantation. J. Biol. Chem., 276, 10253-10262.
6. Sternlicht,M.D. et al. (2001) How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol., 17, 463-516.
7. Stamenkovic,I. (2000) Matrix metalloproteinases in tumor invasion and metastasis. Semin. Cancer Biol., 10, 415-433.
8. Brinckerhoff,C.E. et al. (2000) Interstitial collagenases as markers of tumor progression. Clin. Cancer Res., 6, 4823-4830.
9. Vihinen,P. et al. (2002) Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets. Int. J. Cancer, 99, 157-166.
10. Van Lint,P. et al. (2006) Matrix metalloproteinase-8: cleavage can be decisive. Cytokine Growth Factor Rev., 17, 217-223.
11. Murray,G.I. et al. (1996) Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nat. Med., 2, 461-462.
12. Murray,G.I. et al. (1998) Matrix metalloproteinases and their inhibitors in gastric cancer. Gut, 43, 791-797.
13. Murray,G.I. et al. (1998) Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer. J. Pathol., 185, 256-261.
14. Ito,T. et al. (1999) Expression of the MMP-1 in human pancreatic carcinoma: relationship with prognostic factor. Mod. Pathol., 12, 669-674.
15. Nikkola,J. et al. (2005) High serum levels of matrix metalloproteinase-9 and matrix metalloproteinase-1 are associated with rapid progression in patients with metastatic melanoma. Clin. Cancer Res., 11, 5158-5166.
16. Minn,A.J. et al. (2005) Genes that mediate breast cancer metastasis to lung. Nature, 436, 518-524.
17. van 't Veer,L.J. et al. (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature, 415, 530-536.
18. Poola,I. et al. (2005) Identification of MMP-1 as a putative breast cancer predictive marker by global gene expression analysis. Nat. Med., 11, 481-483.
19. Freije,J.M. et al. (1994) Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J. Biol. Chem., 269, 16766-16773.
20. Nielsen,B.S. et al. (2001) Collagenase-3 expression in breast myofibroblasts as a molecular marker of transition of ductal carcinoma in situ lesions to invasive ductal carcinomas. Cancer Res., 61, 7091-7100.
21. Johansson,N. et al. (1999) Collagenase-3 (MMP-13) is expressed by tumor cells in invasive vulvar squamous cell carcinomas. Am. J. Pathol., 154, 469-480.
22. Airola,K. et al. (1997) Human collagenase-3 is expressed in malignant squamous epithelium of the skin. J. Invest. Dermatol., 109, 225-231.
23. Airola,K. et al. (1999) Expression of collagenases-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas. Br. J. Cancer, 80, 733-743.
24. Pendas,A.M. et al. (2000) An overview of collagenase-3 expression in malignant tumors and analysis of its potential value as a target in antitumor therapies. Clin. Chim. Acta, 291, 137-155.
25. Luukkaa,M. et al. (2006) Association between high collagenase-3 expression levels and poor prognosis in patients with head and neck cancer. Head Neck, 28, 225-234.
26. Rizki,A. et al. (2008) A human breast cell model of preinvasive to invasive transition. Cancer Res., 68, 1378-1387.
27. Uria,J.A. et al. (1997) Regulation of collagenase-3 expression in human breast carcinomas is mediated by stromal-epithelial cell interactions. Cancer Res., 57, 4882-4888.
28. Wu,N. et al. (2003) Comparison of mouse matrix metalloproteinase 13 expression in free-electron laser and scalpel incisions during wound healing. J. Invest. Dermatol., 121, 926-932.
29. Inada,M. et al. (2004) Critical roles for collagenase-3 (Mmp13) in development of growth plate cartilage and in endochondral ossification. Proc. Natl Acad. Sci. USA, 101, 17192-17197.
30. Stickens,D. et al. (2004) Altered endochondral bone development in matrix metalloproteinase 13-deficient mice. Development, 131, 5883-5895.
31. Madlener,M. et al. (1998) Matrix metalloproteinases (MMPs) and their physiological inhibitors (TIMPs) are differentially expressed during excisional skin wound repair. Exp. Cell Res., 242, 201-210.
32. Hartenstein,B. et al. (2006) Epidermal development and wound healing in matrix metalloproteinase 13-deficient mice. J. Invest. Dermatol., 126, 486-496.
33. Lafleur,M.A. et al. (2005) Upregulation of matrix metalloproteinases (MMPs) in breast cancer xenografts: a major induction of stromal MMP-13. Int. J. Cancer, 114, 544-554.
34. Nielsen,B.S. et al. (2008) Matrix metalloproteinase 13 is induced in fibroblasts in polyomavirus middle T antigen-driven mammary carcinoma without influencing tumor progression. PLoS ONE, 3, e2959.
35. Vosseler,S. et al. (2005) Angiogenesis inhibition by vascular endothelial growth factor receptor-2 blockade reduces stromal matrix metalloproteinase expression, normalizes stromal tissue, and reverts epithelial tumor phenotype in surface heterotransplants. Cancer Res., 65, 1294-1305.
36. Vosseler,S. et al. (2009) Distinct progression-associated expression of tumor and stromal MMPs in HaCaT skin SCCs correlates with onset of invasion. Int. J. Cancer, 125, 2296-2306.
37. Miller,D.W. et al. (2005) Rapid vessel regression, protease inhibition, and stromal normalization upon short-term vascular endothelial growth factor receptor 2 inhibition in skin carcinoma heterotransplants. Am. J. Pathol., 167, 1389-1403.
38. Fusenig,N.E. et al. (1983) Growth and differentiation characteristics of transformed keratinocytes from mouse and human skin in vitro and in vivo. J. Invest. Dermatol., 81, 168s-175s.
39. Fusenig,N.E. et al. (1978) Characteristics of chemically transformed mouse epidermal cells in vitro and in vivo. Bull. Cancer, 65, 271-280.
40. Stacey,A. et al. (1997) Routine testing of cell cultures and their products for mycoplasma contamination. Methods Mol. Biol., 75, 305-311.
41. Todaro,G.J. et al. (1963) Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines. J. Cell Biol., 17, 299-313.
42. Mueller,M.M. et al. (2004) Friends or foes-bipolar effects of the tumour stroma in cancer. Nat. Rev. Cancer, 4, 839-849.
43. Obermueller,E. et al. (2004) Cooperative autocrine and paracrine functions of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the progression of skin carcinoma cells. Cancer Res., 64, 7801-7812.
44. Pfaffl,M.W. (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res., 29, e45.
45. Cowell,S. et al. (1998) Induction of matrix metalloproteinase activation cascades based on membrane-type 1 matrix metalloproteinase: associated activation of gelatinase A, gelatinase B and collagenase 3. Biochem. J., 331(Pt 2), 453-458.
46. Overall,C.M. et al. (2002) Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat. Rev. Cancer, 2, 657-672.
47. Bergers,G. et al. (2000) Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat. Cell Biol., 2, 737-744.
48. Zigrino,P. et al. (2009) Stromal expression of MMP-13 is required for melanoma invasion and metastasis. J Invest Dermatol., 129, 2686-2693.
49. Fallowfield,J.A. et al. (2007) Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis. J. Immunol., 178, 5288-5295.
50. Zijlstra,A. et al. (2004) Collagenolysis-dependent angiogenesis mediated by matrix metalloproteinase-13 (collagenase-3). J. Biol. Chem., 279, 27633-27645.
51. Toriseva,M.J. et al. (2007) Collagenase-3 (MMP-13) enhances remodeling of three-dimensional collagen and promotes survival of human skin fibroblasts. J. Invest. Dermatol., 127, 49-59.
52. Knauper,V. et al. (1997) The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction. J. Biol. Chem., 272, 7608-7616.
53. Licht,A.H. et al. (2006) JunB is required for endothelial cell morphogenesis by regulating core-binding factor beta. J. Cell Biol., 175, 981-991.
54. Goerges,A.L. et al. (2004) pH regulates vascular endothelial growth factor binding to fibronectin: a mechanism for control of extracellular matrix storage and release. J. Biol. Chem., 279, 2307-2315.